{"id_": "1239214709993283587", "raw_data": {"created_at": "Sun Mar 15 15:39:45 +0000 2020", "id": 1239214709993283587, "id_str": "1239214709993283587", "full_text": "@KaiGehring In der Tat hat #CureVac gerade noch einmal bekräftigt, dass die Arbeit an einem Impfstoff gegen #COVID19 allen PatientInnen zugute kommen soll: https://t.co/au5RBNBFao Gemeinsam mit @CEPIvaccines muss diese Arbeit jetzt weitergehen.", "truncated": false, "display_text_range": [12, 244], "entities": {"hashtags": [{"text": "CureVac", "indices": [27, 35]}, {"text": "COVID19", "indices": [108, 116]}], "symbols": [], "user_mentions": [{"screen_name": "KaiGehring", "name": "Kai Gehring", "id": 110368456, "id_str": "110368456", "indices": [0, 11]}, {"screen_name": "CEPIvaccines", "name": "CEPI", "id": 784351656355897344, "id_str": "784351656355897344", "indices": [194, 207]}], "urls": [{"url": "https://t.co/au5RBNBFao", "expanded_url": "https://www.curevac.com/de/news/curevac-focuses-on-the-development-of-mrna-based-coronavirus-vaccine-to-protect-people-worldwide", "display_url": "curevac.com/de/news/cureva…", "indices": [156, 179]}]}, "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "in_reply_to_status_id": 1239193173513179136, "in_reply_to_status_id_str": "1239193173513179136", "in_reply_to_user_id": 110368456, "in_reply_to_user_id_str": "110368456", "in_reply_to_screen_name": "KaiGehring", "user_id": 2557211461, "user_id_str": "2557211461", "geo": null, "coordinates": null, "place": null, "contributors": null, "is_quote_status": false, "retweet_count": 7, "favorite_count": 15, "reply_count": 2, "quote_count": 1, "conversation_id": 1239192692359389184, "conversation_id_str": "1239192692359389184", "favorited": false, "retweeted": false, "possibly_sensitive": false, "possibly_sensitive_editable": true, "lang": "de", "supplemental_language": null}}